• 1
    Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG: Estimates of human fertility and pregnancy loss. Fertil Steril 1996; 65:503509.
  • 2
    Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early pregnancy. N Engl J Med 2001; 345:14001408.
  • 3
    Boomsma CM, Kavelaars A, Eijkemans MJC, Lentjes EG, Fauser BCJM, Heijnen CJ, Macklon NS: Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod 2009; 24:14271435.
  • 4
    Rock JA, Zacur HA: The clinical management of repeated early pregnancy wastage. Fertil Steril 1983; 39:123140.
  • 5
    Salat-Baroux J: Recurrent spontaneous abortions. Reprod Nutr Dev 1988; 28:15551568.
  • 6
    Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC: Incidence of early loss of pregnancy. N Engl J Med 1988; 319:189194.
  • 7
    Metaferia AM, Muula AS: Stillbirths and hospital early neonatal deaths at Queen Elizabeth Central Hospital, Blantyre-Malawi. Int Arch Med 2009; 2:25.
  • 8
    Horta BL, Victora CG, Menezes AM, Halpern R, Barros FC: Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol 1997; 11:140151.
  • 9
    Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, Bencini E, Menicucci A, Baricordi OR: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002; 32:311315.
  • 10
    Vercammen MJ, Verloes A, Van de Velde H, Haentjens P: Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update 2008; 14:209218.
  • 11
    Borgatti M, Rizzo R, Canto MB, Fumagalli D, Renzini MM, Fadini R, Stignani M, Baricordi OR, Gambari R: Release of sICAM-1 in oocytes and in vitro fertilized human embryos. PLoS ONE 2008; 3:e3970.
  • 12
    Souter I, Huang A, Martinez-Maza O, Breen EC, Decherney AH, Chaudhuri G: Nathan Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-alpha, and interleukin-6 in in vitro fertilization cycles. Fertil Steril 2009; 91:20122019.
  • 13
    Boomsma CM, Kavelaars A, Eijkemans MJ, Fauser BC, Heijnen CJ, Macklon NS: Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril 2009; [Epub ahead of print].
  • 14
    Chaouat G: Innately moving away from the Th1/Th2 paradigm in pregnancy. Clin Exp Immunol 2003; 131:393395.
  • 15
    Croy BA, Esadeg S, Chantakru S, Van Den Heuvel M, Paffaro VA, He H, Black GP, Ashkar AA, Kiso Y, Zhang J: Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol 2003; 59:175191.
  • 16
    Croy BA, He H, Esadeg S, Wei Q, McCartney D, Zhang J, Borzychowski A, Ashkar AA, Black GP, Evans SS, Chantakru S, Van Den Heuvel M, Paffaro VA Jr, Yamada AT: Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction 2003; 126:149160.
  • 17
    Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G: Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005; 83:598605.
  • 18
    Coulam CB: Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 26:2327.
  • 19
    Ford HB, Schust DJ: Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009; 2:7683.
  • 20
    Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:9399.
  • 21
    Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767773.
  • 22
    Kwak JY, Beer AE, Kim SH, Mantouvalos HP: Immunopathology of the implantation site utilizing monoclonal antibodies to natural killer cells in women with recurrent pregnancy losses. Am J Reprod Immunol 1999; 41:9198.
  • 23
    Srinivas SK, Ernst LM, Edlow AG, Elovitz MA: Can placental pathology explain second-trimester pregnancy loss and subsequent pregnancy outcomes? Am J Obstet Gynecol 2008; 199:402.e1402.e5.
  • 24
    Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE: Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 2007; 147:227235.
  • 25
    Bollapragada S, Youssef R, Jordan F, Greer I, Norman J, Nelson S: Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix. Am J Obstet Gynecol 2009; 200:104.e1104.e11.
  • 26
    Romero R, Gotsch F, Pineles B, Kusanovic JP: Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; 65:S194S202.
  • 27
    Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W, On behalf of the NNRN: Perinatal Systemic Inflammatory Response Syndrome and Retinopathy of Prematurity. Pediatr Res 2009; [Epub ahead of print].
  • 28
    Kwak-Kim J, Yang KM, Gilman-Sachs A: Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynaecol Res 2009; 35:609622.
  • 29
    Xie F, Hu Y, Turvey SE, Magee LA, Brunham RM, Choi KC, Krajden M, Leung PC, Money DM, Patrick DM, Thomas E, Von Dadelszen P: Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsia. BJOG 2010; 117:99108.
  • 30
    ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;78:179190.
  • 31
    Gallucci S, Matzinger P: Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13:114119.
  • 32
    Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12:9911045.
  • 33
    Wiedermann U, Chen XJ, Enerback L, Hanson LA, Kahu H, Dahlgren UI: Vitamin A deficiency increases inflammatory responses. Scand J Immunol 1996; 44:578584.
  • 34
    Gerlofs-Nijland ME, Rummelhard M, Boere AJ, Leseman DL, Duffin R, Schins RP, Borm PJ, Sillanpaa M, Salonen RO, Cassee FR: Particle induced toxicity in relation to transition metal and polycyclic aromatic hydrocarbon contents. Environ Sci Technol 2009; 43:47294736.
  • 35
    Kunz M, Ibrahim SM: Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009;2009:979258.
  • 36
    Clark DA, Chaput A, Tutton D: Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA/J × DBA/2 fetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity. J Immunol 1986; 136:16681675.
  • 37
    De Fougerolles AR, Baines MG: Modulation of the natural killer cell activity in pregnant mice alters the spontaneous abortion rate. J Reprod Immunol 1987; 11:147153.
  • 38
    Duclos AJ, Haddad EK, Baines MG: Presence of activated macrophages in a murine model of early embryo loss. Am J Reprod Immunol 1995; 33:354366.
  • 39
    Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG: Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447458.
  • 40
    Tangri S, Wegmann T, Lin H, Raghupathy R: Maternal anti-placental reactivity in natural, immunologically-mediated fetal resorptions. J Immunol 1994; 152:49034911.
  • 41
    Clark DA, Croitoru K: TH1/TH2,3 imbalance due to cytokine-producing NK, gammadelta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy. Am J Reprod Immunol 2001; 45:257265.
  • 42
    Deanesly R: Termination of early pregnancy in rats after ovariectomy is due to immediate collapse of the progesterone dependent decidua. J Reprod Fertil 1973; 35:183186.
  • 43
    Critchley HOD, Kelly RW, Lea RG, Drudy TA, Jones RL, Baird DT: Uterus and endometrium: sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod 1996; 11:22572262.
  • 44
    Clark DA, Quarrington C, Banwatt D, Manuel J, Fulop G: Spontaneous abortion in immunodeficient SCID mice. Am J Reprod Immunol 1994; 32:1525.
  • 45
    Koga K, Mor G: Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci 2008; 15:231242.
  • 46
    Abrahams VM, Aldo PB, Murphy SP, Visintin I, Koga K, Wilson G, Romero R, Sharma S, Mor G: TLR6 Modulates First Trimester Trophoblast Responses to Peptidoglycan. J Immunol 2008; 180:60356043.
  • 47
    Lin Y, Zeng Y, Di J, Zeng S: Murine CD200+ CK7+ trophoblasts in a poly (I:C)-induced embryo resorption model. Reproduction 2005; 130:529537.
  • 48
    Lin Y, Zeng Y, Zeng S, Wang T: Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption. Fertil Steril 2006; 85(Suppl 1):11251129.
  • 49
    Zhang J, Wei H, Wu D, Tian Z: Toll-like receptor 3 agonist induces impairment of uterine vascular remodeling and fetal losses in CBA × DBA/2 mice. J Reprod Immunol 2007; 74:6167.
  • 50
    Ilievski V, Lu SJ, Hirsch E: Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci 2007; 14:315320.
  • 51
    Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009; 183:11441154.
  • 52
    Mor G, Romero R, Aldo PB, Abrahams VM: Is the trophoblast an immune regulator? The role of Toll-like receptors during pregnancy. Crit Rev Immunol 2005; 25:375388.
  • 53
    Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA: Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 2009; 80:243248.
  • 54
    Arck PC, Troutt AB, Clark DA: Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion. Am J Reprod Immunol 1997; 37:262266.
  • 55
    Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA: Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol 1998; 160:545549.
  • 56
    Hudic I, Fatusic Z: Progesterone – induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion. J Perinat Med 2009; 37:338342.
  • 57
    Chen D, Weber M, Lechler R, Dorling A: NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model. Xenotransplantation 2006; 13:408414.
  • 58
    Beutler B: Toll-like receptors: how they work and what they do. Curr Opin Hematol 2002; 9:210.
  • 59
    Drake T, Morrissey J, Edgington T: Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:10871097.
  • 60
    Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999; 341:586592.
  • 61
    Esmon CT: Crosstalk between inflammation and thrombosis. Maturitas 2004; 47:305314.
  • 62
    Boehme MW, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP: Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology 1996; 87:134140.
  • 63
    Nan B, Lin P, Lumsden AB, Yao Q, Chen C: Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res 2005; 115:417426.
  • 64
    Neyrinck AP, Liu KD, Howard JP, Matthay MA: Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol 2009; 158:10341047.
  • 65
    Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997; 272:L197L202.
  • 66
    Chen Y, Peng J, Liu X, Wu J, Li R, Zheng X: Activated protein cameliorates TNF-alpha-induced inflammatory response of endothelium via the endothelial protein C receptor. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2009; 26:625630.
  • 67
    Beer AE, Kwak JY, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35:376382.
  • 68
    Coulam CB, Roussev RG: Correlation of NK cell activation and inhibition markers with NK cytotoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003; 20:5862.
  • 69
    Hiby SE, Walker JJ, O’Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957965.
  • 70
    Cudihy D, Lee RV: The pathophysiology of pre-eclampsia: current clinical concepts. J Obstet Gynaecol 2009; 29:576582.
  • 71
    Bachmayer N, Sohlberg E, Sundstrom Y, Hamad RR, Berg L, Bremme K, Sverremark-Ekstrom E: Women with pre-eclampsia have an altered NKG2A and NKG2C receptor expression on peripheral blood natural killer cells. Am J Reprod Immunol 2009; 62:147157.
  • 72
    Gilman-Sachs A, DuChateau BK, Aslakson CJ, Wohlgemuth GP, Kwak JY, Beer AE, Beaman KD: Natural killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 1999; 41:99105.
  • 73
    Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee SK, Beaman K: Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertil Steril 2008; 89:157165.
  • 74
    Vargas RG, Bompeixe EP, Franca PP, Marques de Moraes M, Da Graca Bicalho M: Activating killer cell immunoglobulin-like receptor genes’ association with recurrent miscarriage. Am J Reprod Immunol 2009; 62:3443.
  • 75
    Carbone J, Gallego A, Lanio N, Navarro J, Orera M, Aguaron A, Fernandez-Cruz E, Sarmiento E: Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome. J Rheumatol 2009; 36:12171225.
  • 76
    Mulla MJ, Brosens JJ, Chamley LW, Giles I, Pericleous C, Rahman A, Joyce SK, Panda B, Paidas MJ, Abrahams VM: Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol 2009; 62:96111.
  • 77
    Perricone C, De Carolis C, Giacomelli R, Zaccari G, Cipriani P, Bizzi E, Perricone R: High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis. Rheumatology (Oxford) 2007; 46:15741578.
  • 78
    Kwak JY, Kwak FM, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996; 35:363369.
  • 79
    Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I: Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000; 15:11631169.
  • 80
    Fukui A, Fujii S, Yamaguchi E, Kimura H, Sato S, Saito Y: Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am J Reprod Immunol 1999; 41:413422.
  • 81
    Heilmann L, Schorsch M, Hahn T: CD3(-)CD56(+)CD16(+) Natural Killer Cells and Improvement of Pregnancy Outcome in IVF/ICSI Failure After Additional IVIG-Treatment. Am J Reprod Immunol 2010; 63:263265.
  • 82
    Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:4046.
  • 83
    Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50:351354.
  • 84
    De Carolis C, Perricone C, Perricone R: NK Cells, Autoantibodies, and Immunologic Infertility: A Complex Interplay. Clin Rev Allergy Immunol 2009; [Epub ahead of print].
  • 85
    Ntrivalas EI, Kwak-Kim JYH, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16:855861.
  • 86
    Faridi RM, Das V, Tripthi G, Talwar S, Parveen F, Agrawal S: Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod 2009; 24:17581764.
  • 87
    Vacca P, Cantoni C, Prato C, Fulcheri E, Moretta A, Moretta L, Mingari MC: Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int Immunol 2008; 20:13951405.
  • 88
    Park DW, Lee HJ, Park CW, Hong SR, Kwak-Kim J, Yang KM: Peripheral blood NK cells reflect changes in decidual NK cells in women with recurrent miscarriages. Am J Reprod Immunol 2010; 63:173180.
  • 89
    Lea R, Flanders K, Harley C, Manuel J, Banwatt D, Clark D: Release of a transforming growth factor (TGF)-beta 2-related suppressor factor from postimplantation murine decidual tissue can be correlated with the detection of a subpopulation of cells containing RNA for TGF- beta 2. J Immunol 1992; 148:778787.
  • 90
    Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arck PC: Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am J Reprod Immunol 2005; 54:203216.
  • 91
    Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122130.
  • 92
    Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127133.
  • 93
    Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A: Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod 2000; 15:20112017.
  • 94
    Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:7786.
  • 95
    Jaattela M, Kuusela P, Saksela E: Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab Invest 1988; 58:4852.
  • 96
    Voigt HJ, Steib L: Tumor necrosis factor and pregnancy – a contribution to the immunology of reproduction. Arch Gynecol Obstet 1989; 246:223226.
  • 97
    Meisser A, Chardonnens D, Campana A, Bischof P: Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999; 5:252260.
  • 98
    Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ: Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15:819835.
  • 99
    Yui J, Hemmings D, Garcia-Lloret M, Guilbert LJ: Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction. Biol Reprod 1996; 55:400409.
  • 100
    Leisser C, Saleh L, Haider S, Husslein H, Sonderegger S, Knofler M: Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol Hum Reprod 2006; 12:601609.
  • 101
    Ho HN, Chao KH, Chen CK, Yang YS, Huang SC: Activation status of T and NK cells in the endometrium throughout menstrual cycle and normal and abnormal early pregnancy. Hum Immunol 1996; 49:130136.
  • 102
    Yang KM, Ntrivalas E, Choi HJ, Kim NY, Beaman K, Gilman-Sachs A, Kwak-Kim J: Women with multiple implantation failures and recurrent pregnancy losses have increased peripheral blood T cell activation. Am J Reprod Immunol 2010; 63:173180.
  • 103
    Kirschbaum M, Jaeger MS, Duschl C: Correlating short-term Ca(2+) responses with long-term protein expression after activation of single T cells. Lab Chip 2009; 9:35173525.
  • 104
    Cebrian M, Yague E, Rincon M, Lopez-Botet M, De LandazuriM, Sanchez-Madrid F: Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988; 168:16211637.
  • 105
    Santis AG, Campanero MR, Alonso JL, Tugores A, Alonso MA, Yague E, Pivel JP, Sanchez-Madrid F: Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur J Immunol 1992; 22:12531259.
  • 106
    Jenkins SJ, Perona-Wright G, MacDonald AS: Full development of Th2 immunity requires both innate and adaptive sources of CD154. J Immunol 2008; 180:80838092.
  • 107
    Fanslow WC, Clifford KN, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell F: Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 1994; 152:42624269.
  • 108
    Noelle RJ: CD40 and its ligand in host defense. Immunity 1996; 4:415419.
  • 109
    Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M: Delespesse Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995; 25:11251128.
  • 110
    Ho HN, Wu MY, Chen HF, Chao KH, Yang YS, Huang SC, Lee TY, Gill TJ III: In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a). Am J Reprod Immunol 1995; 33:134139.
  • 111
    Funderburg N, Luciano AA, Jiang W, Rodriguez B, Sieg SF, Lederman MM: Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS ONE 2008; 3:E1915.
  • 112
    MArquard K, Westphal LM, Milki AA, Lathi RB: Etiology of recurrent pregnancy loss in women over the age of 35 years. Fertil Steril 2009; [Epub ahead of print].
  • 113
    Blank N, Schiller M, Krienke S, Busse F, Schatz B, Ho AD, Kalden JR, Lorenz HM: Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis. J Immunol 2007; 179:36133621.
  • 114
    Hillyard DZ, Cameron AJ, McDonald KJ, Thomson J, MacIntyre A, Shiels PG, Panarelli M, Jardine AG: Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease. Atherosclerosis 2004; 175:305313.
  • 115
    Attia GR, Rainey WE, Carr BR: Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 2001; 76:517524.
  • 116
    Mansfield R, Galea R, Brincat M, Hole D, Mason H: Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril 2003; 79:956962.
  • 117
    Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, Arteel GE: Metformin Prevents Endotoxin-Induced Liver Injury after Partial Hepatectomy. J Pharmacol Exp Ther 2006; 316:10531061.
  • 118
    Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N, Schonbeck U: Libby Metformin Inhibits Proinflammatory Responses and Nuclear Factor-{kappa}B in Human Vascular Wall Cells. Arterioscler Thromb Vasc Biol 2006; 26:611617.
  • 119
    Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, Tajima T, Yano T, Taketani Y: Metformin Suppresses Interleukin (IL)-1{beta}-Induced IL-8 Production, Aromatase Activation, and Proliferation of Endometriotic Stromal Cells. J Clin Endocrinol Metab 2007; 92:32133218.
  • 120
    Morin-Papunen L, Rautio K, Ruokonen A, Hedberg P, Puukka M, Tapanainen JS: Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2003; 88:46494654.